TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›LIFE

LIFE

Ethos Technologies Inc.

Last earnings +9.8% on 2026-05-06

Hold
$19.59
▲ +3.65%
$19.59▲ +16.26%
over 1Y
L $9.85H $30.59
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.7%
1W+5.2%
1M+13.4%
3M+65.0%
YTD+16.3%
1Y+16.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 15 analysts
Strong Buy

Genuinely fast-growing, profitable insurtech — but the headline 'cheap' multiples rest on a share count the 10-K itself contradicts.

Revenue $388M · FY2025

The read

Middling fundamentals offset by an attractive price (~137% below fair value) — worth a look on the value angle.

Ethos is a high-quality growth story on the surface: FY2025 revenue of $388M grew 52% YoY, net income of $71.2M grew 46% at an 18.4% net margin, operating income rose 50%, and operating cash flow jumped to $36.2M (+432%). The platform model — earning carrier commissions on activated life-insurance policies sold digitally — scales well, and cash of $91.1M (+160%) plus negligible capex ($1.49M) give it room to fund growth without leaning on its balance sheet. On the provided 16.6M-share basis, a 15.5x P/E and 0.8x P/S would be conspicuously cheap for that growth.

The problem is that those headline multiples are almost certainly wrong. The 10-K discloses 30,790,388 Class A plus 32,079,265 Class B shares outstanding as of Feb 28, 2026 — roughly 63M shares, nearly 4x the 16.6M used to derive the $315M market cap, P/E and P/S. On the real diluted base the stock trades closer to ~3x sales and a P/E in the 40s — i.e., roughly fair for ~50% growth (PEG near 1), not the bargain the screen implies. I will not invent a precise valuation off a share count the filing contradicts, hence no price target.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 1:03 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY24FY25
Revenue$255M$388M
Gross profit——
Operating income$48.7M$72.9M
Net income$48.8M$71.2M
Diluted EPS$0.85$1.22
Net margin19.2%18.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.77B
EV / EBITDA22.6
EV / Sales4.6
EV / FCF51.0
P / FCF53.6
PEG (trailing)0.35
Earnings yield3.8%
FCF yield1.9%

Quality & risk

ROIC (est.)—
Free cash flow$34.7M
Total debt—
Net cash$91.1M
Altman Z-Score9.50 safe
Piotroski F-Score4/7

Capital returns

Buyback yield—
Dividend yield (est.)0.0%
Shareholder yield0.0%
Shares Δ YoY+3.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 10-Q Quarterly report2026-05-08

    First 10-Q as a public company, period ended 3/31/26

  2. 8-K Earnings results2026-05-06

    Q1 FY26 earnings release (qtr end 3/31); first results since Jan IPO

  3. 10-K Annual report2026-03-17

    FY25 10-K: revenue +52% to $388M, NI $71M, OCF +432%; equity still negative

  4. 8-K Earnings results2026-02-25

    FY25 results: revenue $388M (+52%), net income $71M (+46%)

  5. 8-K Material agreement2026-02-02

    Post-IPO charter & dual-class A/B structure adopted; material agreement entered

  6. S-1/A Securities registration2026-01-20

    Final IPO amendment; Class A listed on Nasdaq as LIFE on Jan 29, 2026

  7. S-1/A Securities registration2025-12-05

    Updated IPO registration with refreshed terms/financials ahead of pricing

  8. S-1 Securities registration2025-09-26

    Initial S-1 filed to go public via a Nasdaq IPO

Recent filings

all on EDGAR ↗
4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-04-282026-05-19open ↗4Period ending 2026-04-282026-05-19open ↗4Period ending 2026-05-142026-05-18open ↗SCHEDULE 13GFiling2026-05-15open ↗144Filing2026-05-15open ↗144Filing2026-05-15open ↗144Filing2026-05-15open ↗144Filing2026-05-15open ↗144Filing2026-05-15open ↗144Filing2026-05-15open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB-
GrowthA+
ProfitabilityA
Financial healthF
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$46.36

Undervalued +137% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.22 × (8.5 + 1.5 × 22.0% growth) × 1.05 quality = 38.0× multiple. An estimate, not a price target.

0.0052-week0.00
Revenue
$388M
+52.0% YoY
Net margin
18.4%
ROE
—
P/E
16.1

SEC fundamentals · FY 2025

'24'25

■ revenue · ■ net income, by fiscal year

Revenue$388M+52.0%
Net income$71.2M+45.7%
Operating income$72.9M+49.6%
Diluted EPS$1.22+43.5%
Cash & equivalents$91.1M+159.7%
Total assets$515M+30.2%
Total liabilities$135M+36.8%
Stockholders' equity-$24.1M+77.5%
Op.: 18.8%L/E: -5.62x

Frequently asked

Is Ethos Technologies Inc. (LIFE) a buy?
LIFE currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Genuinely fast-growing, profitable insurtech — but the headline 'cheap' multiples rest on a share count the 10-K itself contradicts.
What is LIFE's fair value?
A Modified-Graham model based on LIFE's SEC fundamentals estimates a fair value of about $46.36. It is an estimate from reported earnings, not a price target.
Is LIFE overvalued or undervalued?
Against a Modified-Graham fair-value estimate, LIFE currently appears undervalued relative to its SEC-grounded earnings power.
What is Ethos Technologies Inc.'s quality score?
LIFE scores 72.21568627450979/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001788451, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/30/2026, 5:03:07 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 11 sales

2026-05-15
Wang Lingke
President
Sell39.5K @ $21.99$868K
2026-05-15
Wang Lingke
President
Sell6.85K @ $22.77$156K
2026-05-15
Wang Lingke
President
Disposed (C)69.5K
2026-05-15
Colis Peter George
CEO and Secretary
Sell54.9K @ $22.00$1.21M
2026-05-15
Colis Peter George
CEO and Secretary
Sell5.14K @ $22.78$117K
2026-05-15
Colis Peter George
CEO and Secretary
Disposed (C)55.8K
2026-05-15
Capozzi Christopher M.
Chief Financial Officer
Sell63.0K @ $21.97$1.38M
2026-05-15
Capozzi Christopher M.
Chief Financial Officer
Sell17.6K @ $22.72$401K
2026-05-15
Kucharski Brandt Walter
Chief Accounting Officer
Sell5.32K @ $22.00$117K
2026-05-15
Kucharski Brandt Walter
Chief Accounting Officer
Sell499.00 @ $22.66$11.3K
2026-05-15
GV 2019 GP, L.L.C.
10% owner
Disposed (J)87.5K
2026-05-15
GV 2019 GP, L.L.C.
10% owner
Sell45.4K @ $23.27$1.06M

Earnings history

beat/miss · move
2026-05-06Beat +138.1% est▲ +9.83%8-K ↗
2026-02-25Beat +6.1% est▲ +3.50%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
William Blair updates conviction list: Oracle in, Meta out and moreBullish
seekingalpha.com· 2026-07-01
Stock Stories, Vol. 12: Time Travel InvestingBullish
nasdaq.com· 2026-06-22
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings GrowthBullish
finance.yahoo.com· 2026-06-08
Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.
finance.yahoo.com· 2026-05-26
Bank of America, Wells Fargo extend losses; Japanese firms in gainers: week's financials wrapBullish
seekingalpha.com· 2026-05-16
SoftBank Trims Tech PortfolioBullish
finance.yahoo.com· 2026-05-15

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score72 vs 67
Revenue growth52.0% vs 7.5%
Net margin18.4% vs 10.0%
Return on equity— vs 12.0%
P/E16.1 vs 26.2

News sentiment

EODHD · 10d
Bearish
-0.23
vs typical · 12 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.